0 participants
Pembrolizumab and Autologous Dendritic Cells for the Treatment of Refractory Colorectal Cancer (CRC)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-09-26
- Start Date:
- 2024-10-01
- Completion:
- 2026-10-01
Conditions
- Metastatic Microsatellite Stable Colorectal Carcinoma
- Recurrent Colorectal Carcinoma
- Stage III Colorectal Cancer AJCC v8
- Stage IV Colorectal Cancer AJCC v8
- Unresectable Colorectal Carcinoma
Interventions
- PROCEDURE
- BIOLOGICAL
No Results Yet